Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial

SUMMARY: The cathepsin K inhibitor, ONO-5334, improves bone mineral density in postmenopausal women with osteoporosis. The effects of morning versus evening administration of ONO-5334 were investigated by measuring bone turnover marker levels in healthy postmenopausal women. Morning administration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Eastell, R., Dijk, D.-J., Small, M., Greenwood, A., Sharpe, J., Yamada, H., Yuba, M., Tanimoto, M., Deacon, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715857/
https://www.ncbi.nlm.nih.gov/pubmed/26446770
http://dx.doi.org/10.1007/s00198-015-3342-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715857/
https://www.ncbi.nlm.nih.gov/pubmed/26446770
http://dx.doi.org/10.1007/s00198-015-3342-4

Ejemplares similares